Latest stories on IMUX
Immunic names Erik Lundgren as CEO as it advances Phase 3 MS trials
Yahoo Finance58 · neutralproduct/pr
Immunic Appoints New CEO to Lead MS Strategy
TipRanks58 · neutralproduct/pr
EXCLUSIVE: Immunic Appoints Former Genentech Exec Erik Lundgren As CEO
Yahoo Top58 · neutralgeneral
Immunic appoints Biogen, Cubist veteran Mike Bonney as board chair ahead of key MS trial readout
Yahoo Top58 · neutralgeneral
Immunic Appoints Michael Bonney as Board Chair
TipRanks53 · neutralgeneral
Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors
PR Newswire58 · neutralproduct/pr
Immunic advances Phase 3 MS program, eyes topline data by year-end
Yahoo Finance58 · neutralproduct/pr
Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update
PR Newswire58 · neutralearnings